Key facts
- Notable investors include Changde Caixin Financial Holding.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Hanhe Biomaterials
- ·The full record, as it builds
Funding rounds
No funding rounds for Hanhe Biomaterials are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hanhe Biomaterials
Manufacturer of bio-based new materials intended for manufacturing, environmental protection, and new energy sectors. The company is engaged in the development and production of bio-resins, biodegradable plastics, and hard carbon anode materials derived from renewable plant resources, thereby enabling clients to reduce carbon emissions, enhance material performance, and achieve cost-effective sustainability.
- Sector
- Materials and Resources
- HQ
- Shanghai, China
- Founded
- 2018
- Employees
- 6
- Website
- hanhexincai.com/
- Ownership
- Privately Held (backing)
Hanhe Biomaterials doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hanhe Biomaterials shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hanhe Biomaterials in its N-PORT filings yet. We sweep new filings monthly.